摘要
目的探讨非小细胞肺癌(NSCLC)的18^F-FDGPET-CT最大标准化摄取值(SUVmax)与临床病理特征的关系。方法回顾性分析105例术前行PET—CT检查的NSCLC患者,对可能影响肿瘤SUVmax的因素,包括性别、年龄、吸烟史、癌胚抗原、肿瘤位置、组织学类型、TNM分期、T分期、N分期、肿瘤大小、脉管浸润和胸膜浸润进行单因素分析和多元回归分析。通过受试者工作特征曲线分析suVmax的诊断效率和最佳诊断界值。结果单因素分析提示suvmax与癌胚抗原(P=0.002)、肿瘤大小(P〈0.001)、组织学类型(P〈0.001)、TNM分期(P〈0.001)、T分期(P〈0.001)、N分期(P〈0.001)、脉管浸润状态(P=0.001)有关;多元线性回归分析显示组织学类型(P=0.004)、肿瘤大小(P=0.036)、N分期(P=0.043)是肿瘤SUVmax的独立影响因素。肿瘤SUVmax对淋巴结转移有预测价值,以6.75为界值时诊断效率最高,敏感度为72.2%,特异度为81.6%。结论NSCLC的18^F-FDGPET-CT与组织学类型、肿瘤大小、淋巴结转移情况相关,非腺癌、肿瘤较大、伴有淋巴结转移者SUVmax较高,肿瘤SUVmax可预测淋巴结转移风险。
Objective To analyze the correlation of clinicopathological characteristics and maximum standardized uptake value (SUVmax) detected by 18^F-FDG PET-CT in non-small cell lung cancer (NSCLC). Methods 105 patients with NSCLC who underwent 18^F-FDG PET-CT scan before surgical resection were reviewed retrospectively. Clinicopathological factors which might affect SUVmax were evaluated, including sex, age, smoking history, CEA level, tumor site, histological type, TNM stage, T factor, N factor, tumor size, lymphovascular invasion and pleural invasion features. Independent factors were identified by multiple regression analysis. The diagnostic efficiency and best cut-off point of SUVmax were calculated by the receiver operating characteristic curve. Results It was identified by the univariate analysis that the CEA level (P = 0.002), tumor size (P 〈 0.001), histological type (P 〈 0.001), TNM stage (P 〈 0.001), T factor (P 〈 0.001), N factor (P 〈 0.001), and lymphovascular invasion (P = 0.001) were factors affecting SUVmax. While histological type (P = 0.004), tumor size (P = 0.036), N factor (P = 0.043) were found to be significant independent factors according to multivariate regression analysis. The SUVmax of primary tumor was a predictor for lymphatic metastasis with the highest diagnostic accuracy at a cut-off value of 6.75, the sensitivity and specificity were 72.2 % and 81.6 %, respectively. Conclusions The SUVmax is correlated with histological type, tumor diameter, nodal status in NSCLC, and is higher in patients with non- adenocarcinoma, lager tumor and lymphatic metastasis. Furthermore, the probability of lymphatic metastasis could be predicted by SUVmax of the primary tumor.
出处
《肿瘤研究与临床》
CAS
2015年第1期1-5,10,共6页
Cancer Research and Clinic
基金
国家临床重点专科建设项目(2011873)
国家外国专家局出国培训项目(20130396)